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Introduction
 Idiopathic pulmonary fibrosis (IPF) is a chronic 
and ultimately fatal disease characterized by scarring 
and chronic pathological remodeling of the lung in 
which the normal tissue architecture is progressively 
replaced by extracellular matrix (ECM) proteins 
including collagens and fibronectin, eventually 
leading to respiratory failure1)2). Pulmonary fibrosis is 
also caused by collagen diseases, viral infections, 
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Abstract 
 The lysophospholipid mediator sphingosine-1-phosphate (S1P) exerts diverse biological activities 
including the regulation of leukocyte migration and vascular barrier integrity, suggesting that S1P 
signaling could be involved in inflammatory fibrotic diseases. Pulmonary fibrosis is a devastating disease 
characterized by fibroblast accumulation and extracellular matrix deposition in lungs, and bleomycin–
induced pulmonary fibrosis is the most widely used experimental model. We studied the effects of the 
S1P–specific receptor S1P2 on the phenotypes of lung fibroblasts isolated from bleomycin- and saline-
administered wild-type and S1P2–null (S1pr2-/-) mice. The lung fibroblasts from bleomycin-administered 
wild-type and S1pr2-/- mice failed to proliferate in the presence of serum, unlike fibroblasts from saline-
administered mice. The fibroblasts from bleomycin-administered mice also showed the enlarged and 
flattened morphology compared with fibroblasts from control mice. Bleomycin administration increased 
the protein expression of the cell cycle inhibitor p16INK4a in fibroblasts and the number of senescence–
associated β-galactosidase (SA-β-gal)-positive fibroblasts. In S1pr2-/- fibroblasts, bleomycin 
administration-induced increases in p16INK4a protein expression and SA–β-gal–positive cells were 
augmented. Furthermore, bleomycin increased mRNA expression of interleukin-6 and matrix 
metalloproteinases in S1pr2-/- fibroblasts compared with wild-type fibroblasts. In addition, the activation 
of Akt in response to platelet–derived growth factor and S1P was enhanced in S1pr2-/- fibroblasts 
compared with wild-type fibroblasts. These results indicate that S1P2 deletion enhances bleomycin 
administration–induced cellular senescence of lung fibroblasts, which may lead to inhibition of lung 
fibrosis through the mechanisms involving increased matrix metalloproteinases expression. Thus, S1P2 
may be a novel therapeutic target for lung fibrosis. 
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Abbreviations: BSA, bovine serum albumin; Ct, threshold cycle; DMEM, Dulbecco’s modified Eagle’s medium; 
cDNA, complementary DNA; ECM, extracellular cellular matrix; EC, endothelial cell; FBS, fetal bovine serum; 
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IgG, immunoglobulin G; IL, interleukin; IPF, idiopathic 
pulmonar y fibrosis; MMP, matrix metalloproteinase; p-Akt; Ser473-phosphor ylated–Akt; p-ERK, Thr202, Tyr204-
phosphorylated–extracellular signal-related kinase; PI, phosphatidylinositol; PDGF, platelet–derived growth factor; 
PTEN, phosphatase and tensin homolog deleted on chromosome 10; p-p53, Ser15-phosphorylated–p53; qPCR 
quantitative polymerase chain reaction; ROS, reactive oxygen species; SA–β-gal, senescence–associated 
β-galactosidase; αSMA, α-smooth muscle actin; S1P, sphingosine-1-phosphate;  S1pr2-/-, S1P2–null; SphK, sphingosine 
kinase; TGF, transforming growth factor; WT, wild-type 
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anti-cancer agents, radiotherapy and aerosolized 
environmental toxins1). As experimental models of 
pulmonary fibrosis, administration of the anticancer 
drug bleomycin into mice and rats is commonly 
employed1)2). Pulmonary fibrosis is likely elicited by 
persistent injury of alveolar epithelial and vascular 
endothelial cells (ECs), which induces the infiltration 
of leukocytes into injured sites. These damaged cells 
and infiltrated leukocytes release inflammatory 
cytokines and profibrogenic factors such as 
interleukin (IL)-6, IL-1β, tumor necrosis factor-α, 
and transforming growth factor-β (TGFβ)1)2). The 
cytokines and profibrogenic factors activate resident 
f i b r o b l a s t s  t o i n d u c e d i f f e r e n t i a t i o n i n t o 
myofibroblasts1)-3). Myofibroblasts migrate and 
accumulate with the excessive synthesis and 
deposition of ECM to form fibrotic lesions1)-3). In 
addition, bone marrow-derived circulating fibrocytes 
and epithelial cells- and EC-derived fibroblasts may 
also contribute to myofibroblasts in fibrotic lesions3). 
 Sphingosine-1-phosphate (S1P) is a pleiotropic 
lysophospholipid mediator and regulates various 
biological processes such as embryonic development, 
angiogenesis, vascular permeability and lymphocyte 
trafficking4)-9). S1P is generated intracellularly by the 
phosphorylation of sphingosine, which is derived 
from the membrane sphingolipids including 
sphingomyel in and g lycosphingol ip ids , by 
sphingosine kinases 1 and 2 (SphK1 and SphK2)4)-9). 
Erythrocytes and vascular ECs export intracellular 
S1P into the plasma through membrane transporters 
including Spns2, contributing to a high (~1 μM) S1P 
concentration in plasma. In contrast, the S1P 
concentration in the interstitial fluid is estimated to 
be very low (several nM). S1P binds to five S1P-
specific G protein-coupled receptors (S1P1-S1P5) to 
mediate many of these S1P actions by stimulating 
distinct but overlapping signaling pathways in a 
receptor subtype-specific manner4)-9). For example, 
S1P1 exclusively couples to Gi and activates 
phosphatidylinositol (PI) 3-kinase-Akt/Rac and Ras-
ERK with stimulation of chemotaxis and cell 
proliferation, whereas S1P2 predominantly couples to 
G12/13 and activates Rho, leading to inhibition of Rac 
and Akt with suppression of cell migration and 
proliferation4)-6).
 S1P regulates migration, proliferation and 
differentiation into myofibroblasts of fibroblasts7). 
Fibroblasts mainly express S1P1, S1P2, and S1P310). 
S1P increased expression of the myofibroblast 
marker α-smooth muscle actin (αSMA) and collagen 
synthesis in fibroblasts11)12). Interestingly, the 
powerful profibrotic cytokine TGFβ stimulated 
expression of αSMA and SphK1, a synthesizing 
enzyme of S1P, in fibroblasts and knockdown of 
either SphK1, S1P2 or S1P3 inhibited TGFβ-induced 
myofibroblast differentiation, suggesting that SphK1-
S1P-S1P2/S1P3 pathway participates in profibrotic 
actions of TGFβ10). Moreover, S1P concentrations in 
serum and bronchoalveolar lavage fluid in patients 
with IPF were elevated with increased expression of 
SphK1 in the lung tissue13). SphK1 expression was 
also increased in bleomycin-induced lung fibrotic 
regions in mice10). Intriguingly, genetic deletion of 
SphK1 attenuated bleomycin-induced lung fibrosis14). 
These obse rva t i ons imp l i ca t ed S1P in t he 
pathogenesis of lung fibrosis7). Recently we have 
observed that S1P2 deficiency reduced bleomycin-
induced lung fibrosis in mice compared with wild-
type (WT) mice (unpublished observation; Zhao J, 
Okamoto Y and Takuwa Y). However, the profibrotic 
role of S1P2 on lung fibrosis remains unknown.
 In this study, we investigated a role of S1P2 in 
fibroblasts isolated from fibrotic lungs of bleomycin-
administered mice, by analyzing and comparing WT 
and S1P2-null (S1pr2-/-) lung fibroblasts. S1P2 
deletion dramatically enhanced bleomycin-provoked 
cellular senescence in lung fibroblasts; augmented 
cellular senescence in S1P2-deficient fibroblasts was 
associated with suppressed cell proliferation and the 
upregulation of the cell cycle inhibitor protein 
p16INK4a, senescence-associated β-galactosidase 
(SA-β-gal), and matrix metalloproteinases (MMPs) 
that degrade ECM proteins. The expression of 
cellular senescent phenotypes in lung fibroblasts of 
S1P2-null mice may affect the development of 
bleomycin-induced lung fibrosis. 
Materials and Methods
Materials
 High-Capacity cDNA Reverse Transcription kit 
was purchased from Applied Biosystems (Foster, 
CA). S1P was bought from Biomol (Plymouth 
Meeting, PA). Rabbit polyclonal anti-p16INK4a 
antibody (sc-1207) was bought from Santa Cruz 
Biotechnology, Inc (Santa Cruz, CA). Rabbit 
polyclonal anti-Ser473-phosphorylated Akt (p-Akt) 
antibody (#4060), rabbit polyclonal anti-Thr202, 
Tyr204-phosphorylated extracellular signal-related 
kinase (p-ERK) antibody (#4370), rabbit polyclonal 
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anti-Akt antibody (#9272), rabbit polyclonal anti-
ERK antibody (#9102), rabbit polyclonal anti-Ser15-
phosphorylated–p53 antibody (p–p53) (#9284), 
mouse monoclonal anti-p53 antibody (#2524), rabbit 
monoclonal anti-glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) antibody (#2118), anti-
r a b b i t  i m m u n o g l o b u l i n  G ( I g G ) a l k a l i n e 
phosphatase-conjugated secondary antibody (#7054), 
anti-mouse IgG alkaline phosphatase-conjugated 
secondary antibody (#7056) were bought from Cell 
Signaling Technology (Beverly, MA). Fetal bovine 
se rum (FBS) was bough t f rom Gibco L i fe 
technologies (Carlsbad, CA). Alamar Blue dye and 
TRIzol® were purchased from Invitrogen (Frederick, 
MD). Sodium pentobarbital was purchased from 
Kyoritsu (Tokyo, Japan). Bleomycin was bought 
from Nippon Kayaku (Tokyo, Japan). Platelet-
derived growth factor-BB (PDGF-BB) was bought 
from Peprotech (Rocky Hill, NJ). Collagenase A and 
FastStart Universal SYBR Green Master were 
bought from Roche (Nutley, NJ). DNase I and fatty 
acid-free bovine serum albumin (BSA) were bought 
from Sigma (St. Louis, MO). Diff-Quik kit was 
bought from Sysmex (Kobe, Japan). Nuclear Fast 
Red (H-3403) was bought from Vector Laboratories 
(Burlingame, CA). 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside, 5-bromo-4-chloro-3-indolyl-
phosphate, nitroblue tetrazolium, RPMI1640 and 
Dulbecco’s modified Eagle’s medium (DMEM) were 
bought from Wako Pure Chemical Co. (Osaka, 
Japan). All other reagents used were obtained from 
Wako Pure Chemical Co., unless otherwise specified.
Mice
 S1P2-null (S1pr2-/-) mice were previously 
described15). S1pr2-/- mice (129Ola; C57BL/6J mixed 
background) were back-crossed with C57BL/6J mice 
(no. 000664; Charles River, Wilmington, Mass) 
once15). All mice were housed in a temperature-
controlled environment (24℃) under a 12/12-hr light/
dark cycle with regular chow and water ad libitum. 
All animal experiments were carr ied out in 
accordance with the Fundamental Guidelines for 
Proper Conduct of Animal Experiment and Related 
Activities in Academic Research Institutions under 
the jurisdiction of the Ministry of Education, Culture, 
Sports, Science and Technology of Japan, and were 
reviewed and approved by the Committee on Animal 
E x p e r i m e n t a t i o n  a n d  r e c o m b i n a n t  D N A 
experimentation of Kanazawa University. Mice were 
genotyped by PCR analysis of genomic DNA 
prepared from tail biopsies using the following 
primers15): F1, 5’-cagtgacaaaagctgccgaatgctgatgct-3’; 
F2, 5’-tggctacccgtgatattgctgaagagcttg-3’; R1, 5’-tgag
cagtgagttaagggtggcaaaggcaa-3’. The PCR conditions 
were: 40 cycles of 94℃ (30 sec), 59℃ (45 sec) and 
72℃ (30 sec) for F1 and R1, and 40 cycles of 94℃ 
(30 sec), 59℃ (45 sec) and 72℃ (30 sec) for F2 and 
R1. The amplified products were 424-bp in the wild-
type allele and 241-bp in the targeted allele.
Bleomycin administration
 WT and S1pr2-/- mice (8-10 week old, 20-25 g 
body weight) were injected intraperitoneally with 
bleomycin (0.035 μg/g body weight) or saline (150 
µl)16). Mice were given bleomycin twice weekly for 4 
weeks and sacrificed on day 22 and 33.
Isolation and culture of primary mouse lung 
fibroblasts 
 Primary mouse lung fibroblasts were isolated from 
lung tissues of bleomycin– or saline–administered 
mice by a previously described method10). Briefly, 
mouse lungs were cut into small pieces, minced, and 
digested enzymatically by collagenase A (1 mg/ml) 
and DNase I (50 U/ml) in DMEM supplemented with 
10% FBS for 90 minutes. After filtration, released 
cells were centrifuged, washed, and cultured in 
DMEM supplemented with 10% FBS. The cells were 
passaged 2 times to obtain pure fibroblasts. The 
fibroblasts between passage 3 and 6 were used in this 
study.
Cell proliferation assay
 Alamar Blue fluorescence assay was performed 
according to the manufacturer’s instructions. Briefly, 
lung fibroblasts were plated in 96-well culture plates 
at a density of 1 × 10³ cells per well in 100 μl of 
10% FBS-containing DMEM in 5% CO2 at 37 ℃ 
under humidified atmosphere for 24 hr. Then, after 
24 hr of serum-free starvation, the cells were cultured 
in 2% FBS-containing DMEM for 4 days. Ten μl of 
Alamar blue dye was added daily to the appropriate 
wel ls and then incubated for 4 hr to a l low 
proliferative cells to react with the reagent. The 
resulting fluorescent intensity (544 nm excitation/590 
nm emission) was measured by a microplate 
fluorometer (Fluoroskan Ascent FL, Thermo Fisher 
Scientific Inc., Waltham, MA). The background 
values in the control wells containing only medium 
were subtracted. Prior to the treatment with 2% FBS, 
Alamar blue dye was added to fibroblasts and the 
fluorescent intensity at day 0 was recorded to 
confirm the similar basic levels in the groups.
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Transwell migration assay
 Transwell migration of lung fibroblasts was 
determined in a modified Boyden chamber (Neuro-
Probe, Gaithersburg, MD) using polycarbonate filters 
with 8-µm pores as previously described17). Lung 
fibroblasts (2.5 × 105 cells) in 200 μl of serum-free 
RPMI1640 containing 0.1% fatty acid-free BSA was 
loaded into the upper wells, whereas the lower wells 
were filled with same medium containing various 
concentrations of S1P and/or PDGF (50 ng/ml). The 
cells were allowed to migrate across the porous filter 
for 6 hr at 37℃ in a CO2 incubator. After staining 
with Diff-Quik and scraping the upper surface of the 
filter, the number of cells that migrated to the lower 
side of filter was determined by measuring optical 
densities at 595 nm using a 96-well microplate reader 
(Multiskan GO, Thermo Fisher Scientific Inc., 
Waltham, MA). 
RNA isolation and real-time quantitative polymerase 
chain reaction (qPCR)
 Total RNA was extracted from lung fibroblasts 
using TRIzol reagent according to the manufacturer’s 
instruction. Two µg of total mRNA was reverse-
transcribed into complementary DNA (cDNA) using 
a High-Capacity cDNA Reverse Transcription kit. 
Target gene expression was quantified with qPCR 
using FastStart Universal SYBR Green Master 
reagent and the ABI PRISM 7300 Sequence 
Detection system (Applied Biosystems, Foster City, 
CA). The condition for qPCR was 10 min at 95℃ , 
followed by 40 cycles of 15 sec at 95℃ and 1 min at 
60℃. The housekeeping gene β-actin was used as an 
internal control. To confirm the amplification 
specificity, PCR products from each primer part were 
subjected to a melting curve analysis and subsequent 
agarose gel electrophoresis. Primers, which were 
designed using Primer3Plus (http: //primer3plus.
com/cgi-bin/dev/primer3plus.cgi) based on published 
sequence data from the Ensembl database (www.
ensembl.org/Mus_musculus/), are listed in Table 1. 
An average threshold cycle (Ct) value was calculated 
from duplicate results for each gene and was 
normalized to that of β-actin to obtain the ΔCt value. 
Western blotting analysis
 Lung fibroblasts were treated as indicated and 
lysed in a cell lysis buffer containing 50 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 1% 
Triton X-100, 1 mM Na3VO4, 10 mM NaF, and 10 
mM Na-β-glycerophosphate by scraping. The cell 
lysates were centrifuged at 15,000 rpm for 15 min at 
4℃ and the resultant supernatants were separated by 
SDS-10% polyacrylamide gels , fol lowed by 
electrotransfer onto Immobilon-P membrane 
(Millipore, Bedford, MA). The membranes were 
blocked with Tris-buffered saline (pH 7.4) containing 
0.1% Tween-80 and 5% non-fat dry milk for 1 hr at 
room temperature and probed with rabbit polyclonal 
anti-Ser473-p-Akt antibody (1: 1000 dilution), rabbit 
polyclonal anti-Thr202, Tyr204-p-ERK antibody (1: 
1000), rabbit polyclonal anti-Akt antibody (1: 1000), 
rabbit polyclonal anti-ERK antibody (1: 1000), rabbit 
polyclonal anti-p16INK4a antibody (1: 500), mouse 
polyclonal anti-p53 antibody (1: 500), rabbit 
polyclonal anti-Ser15-p–p53 antibody (1: 500) or 
rabbit monoclonal anti-GAPDH antibody (1: 1000). 
The bound antibodies were visualized using anti-
rabbit or anti-mouse IgG alkaline phosphatase–
conjugated secondary antibody (1: 1000) and 
5-bromo-4-chloro-3-indolyl phosphate and nitro blue 
tetrazolium. Relative quantification of proteins was 
determined by scanning and band densitometry using 
Image Gauge software (Fuji Photo Film Co, Ltd, 
Tokyo, Japan). 
SA-β-gal staining
 SA-β-gal activity was performed as previously 
described with sl ight modifications18). Lung 
fibroblasts were washed twice with PBS and fixed in 
PBS containing 2% paraformaldehyde and 0.2% 
glutaraldehyde. Then, the cells were washed with PBS 
and incubated overnight at 37℃ with a freshly prepared 
SA-β-gal staining solution containing 1 mg/ml 5- 
bromo-4-chloro-3-indolyl-β-D-galactopyranoside, 40 
mM citric acid-phosphate buffer (pH 6.0), 5 mM 
p o t a s s i u m f e r r o c y a n i d e , 5 m M p o t a s s i u m 
ferricyanide, 2 mM MgCl2 and 150 mM NaCl. The 
cells were counterstained with Nuclear Fast Red. The 
number of SA-β-gal-positive cells per total number 
of cells in the same field was determined by counting 
least 10 fields (x400) under bright-field microscope 
(BX 41; Olympus, Tokyo, Japan). 
Statistical analysis
 All values are expressed as means ± SEM. 
Statistical significance of differences were analyzed 
with Prism 6 software (GraphPad Software, San 
Diego, CA) using two-way ANOVA followed by 




Effects of S1P2 deletion on cell proliferation and 
migration of lung fibroblasts from bleomycin-
administered and non-administered mice
 We followed cell proliferation of lung fibroblasts 
in the presence of 2% FBS for 4 days. The fibroblasts 
from saline-administered S1pr2-/- mice more 
robustly proliferated than the cells from saline-
administered WT mice (Fig. 1). In contrast to 
fibroblasts from saline-administered mice, the 
fibroblasts from bleomycin-administered WT or 
S1pr2-/- mice did not proliferate in the presence of 
2% FBS. The f ib rob las t s f rom b leomycin-
administered WT and S1pr2-/- mice were enlarged 
and flattened compared with fibroblasts from saline-
administered mice (data not shown). 
 We studied the effects of S1P2 deficiency on cell 
migration of lung fibroblasts, using a transwell 
migration assay. PDGF directed chemotaxis in both 
WT and S1pr2-/- fibroblasts, whether they were 
derived from saline- or bleomycin-administered mice 
(Fig. 2 A and B). However, the migratory responses 
to PDGF were sluggish in lung fibroblasts from 
bleomycin-administered S1pr2-/- mice. S1P induced 
dose-dependent inhibition of PDGF-directed 
chemotaxis and random migration without PDGF in 
WT fibroblasts from saline- and bleomycin-
administered mice. In contrast, S1P did not inhibit 
PDGF-directed chemotaxis or random migration in 
S1pr2-/- fibroblasts. Thus, S1P2 mediated S1P-
induced inhibit ion of cell migration in lung 
fibroblasts as previously observed in other types of 
cells including vascular smooth muscle cells and 
tumor cells19)20). 
Fig. 1. Cell proliferation of lung fibroblasts isolated from WT and 
S1pr2-/- mice with bleomycin or saline administration.
 The lung fibroblasts isolated from WT and S1pr2-/- mice on 
day 33 after starting administration of bleomycin or saline 
were serum-starved for 24 hr and the proliferation of cells in 
the presence of 2% FBS was determined using Alamar Blue 
assay. Data are shown the means ± SEM (n=8) and are 
representative of three independent experiments. The closed 
and open circles / triangles represent lung fibroblasts from 
WT and S1pr2-/- mice, respectively. The circles and triangles 
represent f ibroblasts f rom sa l ine– and b leomycin–
administered mice, respectively. The values at day 0 were 
expressed as 100%. The symbols ** and **** denote statistical 
significance at the levels of P<0.01 and P<0.0001, respectively, 
compared with the values of f ibroblasts from saline-
administered WT mice.
Fig. 2. Migration of lung fibroblasts isolated from WT and S1pr2-
/- mice with or without bleomycin challenge.
 Transwell migration of lung f ibroblasts from sal ine-
administered mice (A) and bleomycin-administrated mice (B) 
was determined in the presence of various concentrations of 
S1P and/or PDGF-BB (50 ng/ml) placed in the lower well of 
the Boyden chamber. The closed and open circles/triangles 
represent lung fibroblasts from WT and S1pr2-/- mice, 
respectively. The circles and triangles represent PDGF-
directed chemotaxis and random migration, respectively. OD 
indicates optical density. Data are means ± SEM from three 
independent experiments, each performed in duplicates. The 
symbols ＊, ＊＊, ＊＊＊ and ＊＊＊＊ denote statistical significance at the 
levels of P<0.05, P<0.01, P<0.001 and P<0.0001, compared with 
the values in the cells without S1P treatment in the same 
group. 
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Effects of S1P2 deletion on mRNA expression of 
inflammatory and profibrotic cytokines in lung 
fibroblasts 
 It has been reported that activated fibroblasts in 
fibrotic lesions produce and secrete inflammatory 
cytokines and profibrotic mediators to further promote 
inflammation and activation of fibroblasts 1)3). The 
mRNA expression of IL-6, IL-1β or TGFβ1 was not 
altered in lung fibroblasts isolated from WT mice 
that received bleomycin (Table 2). In S1pr2-/- lung 
fibroblasts, bleomycin administration increased 
mRNA expression of IL-6 but not IL-1β or TGFβ1. 
IL-6 mRNA leve l in lung f ib rob las t s f rom 
bleomycin-administered S1pr2-/- mice was higher 
compared with the WT counterpart. 
Effects of S1P2 deficiency on bleomycin-induced 
p16INK4a expression and SA-β-gal activity in lung 
fibroblasts
 The fibroblasts from bleomycin-administered 
mice exhibited suppression of cell proliferation, 
morphological changes, and upregulation of IL-6 
expression compared with control fibroblasts (Fig.1 
and Table 2), raising the possibility that they might be 
senescent21). We tested this possibility by examining 
expression of the cellular senescence markers p16INK4a 
and SA-β-gal activity in lung fibroblasts. Bleomycin 
administration increased the protein expression of 
the cell cycle inhibitor p16INK4a in fibroblasts isolated 
from either WT or S1pr2-/- mice (Fig. 3A). The 
expression of p16INK4a in S1pr2-/- fibroblasts from 
bleomycin-administered mice was higher compared 
with the WT counterpart. We also examined another 
cellular senescence marker p53 protein and Ser18 
phosphorylation of p53 (corresponding to Ser15 in 
human p53), which is induced by DNA damage, in 
lung fibroblasts22). Bleomycin administration did not 
increase p53 protein or p-p53 in WT or S1pr2-/- 
fibroblasts (Fig. 3B). SA-β-gal–positive cells were 
negligible in both WT and S1pr2-/- lung fibroblasts 
from saline-administered mice whereas SA-β-gal–
positive cells were increased in fibroblasts from 
bleomycin-administered WT mice (Fig. 4). SA-β-gal- 
positive cells were further increased in fibroblasts from 
bleomycin-administered S1pr2-/- mice. These results 
together indicated that bleomycin administration 
induced cellular senescence of lung fibroblasts, which 
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Messenger RNA levels in lung fibroblasts isolated on day 33 
after starting administration of saline or bleomycin were 
determined with qPCR. The values shown were obtained by 
multiplying ∆Ct values ((Ct of gene of interest) - (Ct of β-actin)) 
by 10-3 for IL-6, TGFβ1, MMP2 and MMP3, by 10-7 for IL-1β, by 
10-6 for MMP1, by 10-5 for MMP9, and by 10-1 for collagen Iα1 
and fibronectin. Data are means ± SEM from three independent 
experiments, each performed in duplicates. The symbols ＊ and 
＊＊＊ denote statistical significance at the level of P＜0.05 and P
＜0.001, respectively, compared with lung fibroblasts isolated 
from saline-administered WT mice. The symbols #, ## and ### 
denote statistical significance at the level of P＜0.05, P＜0.01 
and P＜0.001, respectively, compared with lung fibroblasts 
isolated from bleomycin-administered WT mice. 
Table 2. Messenger RNA expression of inflammatory cytokines, 
matrix metalloproteinases and extracellular matrix proteins in 
lung fibroblasts from WT and S1pr2-/- mice with and without 
bleomycin administration
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Fig. 3. Expression of p16INK4a and p53 proteins in lung fibroblasts isolated from WT and S1pr2-/- mice with bleomycin or saline 
administration.
 Protein expression of p16INK4a (A), and total p53 and p-p53 (B) was determined with Western blotting in lung fibroblasts isolated from WT 
and S1pr2-/- mice on day 33 after starting administration of bleomycin or saline. In (A) and (B), GAPDH was used as an internal control. 
Top: representative blots. Bottom: quantified data. The bar graph represents the quantified data of p16INK4a and p-p53 proteins which were 
normalized to that of GAPDH and total p53, respectively, and expressed as fold-changes relative to the levels in fibroblasts from 
bleomycin-administered WT mice (A) or saline-administered WT mice (B). Data are means ± SEM from three independent experiments. 
The numbers in parentheses denote the analyzed data numbers throughout the Figures. The closed and open bars represent lung 
fibroblasts from WT and S1pr2-/- mice, respectively. The symbols denote the similar levels of statistical significance as described in Fig. 2. 
n.s.: not significant.
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Effects of S1P2 deletion on activation of Akt and 
ERK in lung fibroblasts 
 Because cellular senescence is known to be 
associated with stimulation of mitogenic signaling 
pathways including PI3K-Akt and Ras-ERK23), we 
studied activation of Akt and ERK with Western 
blotting using anti-phospho-specific antibodies in 
lung f ib rob las t s i so la ted f rom b leomycin-
administered mice. The baseline level of p-Akt was 
similar between WT and S1pr2-/- lung fibroblasts. In 
WT fibroblasts, the addition of S1P reduced the level 
of p-Akt whereas S1P tended to increase p-Akt in 
S1pr2-/- fibroblasts (Fig. 5A). This was probably 
because in WT fibroblasts S1P2–mediated Akt 
inhibition predominated over S1P1–mediated Akt 
phosphorylation whereas in S1pr2-/- fibroblasts S1P 
stimulated Akt phosphorylation via S1P1. PDGF 
markedly increased p-Akt in both WT and S1pr2-/- 
lung fibroblasts. S1P tended to reduce PDGF-
induced p-Akt increase in WT fibroblasts whereas 
S1P tended to enhance PDGF-induced increase in 
p-Akt in S1pr2-/- fibroblasts. In contrast to Akt, a 
change in ERK activation by PDGF or S1P was not 
detected (Fig. 5B). Thus, S1P2 exerts an inhibitory 
effect on PDGF-induced Akt activation. 
Effects of S1P2 deletion on mRNA expression of 
MMPs and ECM proteins in lung fibroblasts
 Because senescent cells are known to release the 
ECM-degrading enzymes MMPs more abundantly 
compared with non-senescent cells, we studied 
mRNA expression of MMPs and also ECM proteins 
in lung fibroblasts22). Administration of bleomycin 
into WT mice did not increase the mRNA expression 
of MMP1, MMP2, MMP3 or MMP9 in lung 
fibroblasts (Table 2). In contrast, bleomycin 
administration into S1pr2-/- mice markedly increased 
the mRNA expression of these MMPs. In WT or 
S1pr2-/- mice, bleomycin administration did not alter 
the mRNA expression of fibronectin or collagen Iα1 
in lung fibroblasts. Also, there was no difference in 
the mRNA expression of fibronectin and collagen 
Iα1 between WT and S1pr2-/- fibroblasts. 
Discussion
 In this study, we demonstrate that administration 
of bleomycin into mice, which is widely employed as 
experimental animal model of lung fibrosis, induces 
cellular senescence of lung fibroblasts and that 
genetic deletion of S1P2 augments bleomycin-
induced senescence of lung fibroblasts. These 
Fig. 4. SA-β-gal staining of lung fibroblasts isolated from WT and S1pr2-/- mice with bleomycin or saline administration.
 The lung fibroblasts isolated from WT and S1pr2-/- mice on day 33 after starting administration of bleomycin or saline were stained for 
SA-β-gal activity. Left: representative photographs of SA-β-gal-positive cells counterstained with nuclear fast red (magnification x 400). 
Right: quantified data of SA-β-gal-positive cells. The cells stained in blue were counted as SA-β-gal-positive cells under a bright field 
microscope. Data are means ± SEM from three independent experiments. The numbers in parentheses denote the analyzed data 
numbers throughout the Figures. The closed and open bars represent lung fibroblasts from WT and S1pr2-/- mice, respectively. The 
symbols denote the similar levels of statistical significance as described in Fig. 2. Scale bar: 200 μm.
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Fig. 5. Activation of Akt and ERK in lung fibroblasts isolated from WT and S1pr2-/- mice with bleomycin administration.
 Phosphorylation of Akt at Ser473 (A) and ERK at Thr202 and Tyr204 (B) was determined with Western blotting. The lung fibroblasts isolated 
from WT and S1pr2-/- mice on day 33 after starting bleomycin administration were serum-starved and treated with PDGF-BB (10 ng/ml) 
and/or S1P (0.3 μM) for 10 minutes. Top: representative blots. Bottom: quantified data. The bar graph shows the density of each band of 
phosphorylated proteins which was normalized to that of total proteins and expressed as fold-changes relative to the levels in non-treated 
fibroblasts. Data are means ± SEM from three independent experiments. The closed and open bars represent lung fibroblasts from WT 
and S1pr2-/- mice, respectively. The symbols denote the similar levels of statistical significance as described in Fig. 2. 
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findings may at least in part account for the lung 
phenotype of bleomycin-administered S1pr2-/- mice.
 Cellular senescence is generally defined as the 
state where cells cannot divide any longer, as a result 
of the responses to a variety of cellular stresses 
including DNA damage, reactive oxygen species 
(ROS), and oncogene activation21)-23). Senescent cells 
are characterized by irreversible growth arrest, 
enlarged nucleus and widely spread cellular 
morphology, increased SA-β-gal activity, and 
upregulation of the cell cycle inhibitors such as 
p16INK4a 21)22). Excessive release of a series of secreted 
proteins such as proinflammatory cytokines, 
chemokines and matrix-degrading enzymes, which is 
called senescence-associated secretory phenotype 
(SASP), is also a striking feature of cellular 
senescence21)22). In the present study, the lung 
fibroblasts isolated from bleomycin-administered 
WT and S1pr2-/- mice showed markedly reduced 
proliferation, an enlarged and flattened morphology, 
increased p16INK4a expression and SA-β-gal activity, 
and enhanced expression of IL-6 and MMPs 
compared with the saline-administered counterparts 
(Figs. 1, 3 and 4 and Table 2), indicating that 
b leomycin adminis t ra t ion induced ce l lu la r 
senescence in lung fibroblasts. 
 One of the major side effects of bleomycin, 
which is a chemotherapeutic agent to be commonly 
used for treating various types of cancer, is lung 
injury, particularly lung fibrosis24). Bleomycin exerts 
cytotoxic effects by causing the cleavage of DNA 
strand, which involves the generation of ROS24). In 
the lung, bleomycin damages pulmonary epithelial 
cells and other types of cells to release various 
substances, collectively called damage-associated 
molecular pattern25)-27). These “danger signals” are 
suggested to directly and indirectly activate 
inflammatory cells, releasing profibrotic cytokines 
which include TGFβ25)-27). ROS generated by the 
bleomycin action may also contribute to the 
development of cel lular senescence of lung 
fibroblasts. 
 A recent study of liver fibrosis showed that entry 
of myof ibroblas ts in to senescence induced 
irreversible proliferative arrest, inhibition of ECM 
accumulation and clearance of myofibroblasts by 
natural killer cells in fibrotic liver28). In other studies, 
the ECM protein CCN1 was shown to promote 
fibroblasts senescence and the expression of MMPs, 
which helped to resolve fibrosis in the cutaneous 
wound healing and liver fibrosis models29)30). Taken 
together, it is suggested that cellular senescence of 
fibroblasts may alleviate fibrosis during tissue repair 
processes in various tissues. Our observations 
suggest that cellular senescence of lung fibroblasts 
could contribute to the attenuation of fibrosis through 
the mechanisms involving reduced fibroblast 
proliferation and increased MMP expression. Notably, 
S1P2 deficiency facilitated cellular senescence of 
lung fibroblasts, suggesting that S1P2 deficiency may 
attenuate fibrosis. In fact, we recently found that 
S1pr2-/- mice given bleomycin showed attenuation of 
lung fibrosis compared with WT mice (unpublished 
observation; Zhao J, Okamoto Y and Takuwa Y). 
Thus, S1P2 might positively regulate the fibrotic 
process through antagonizing progression of 
fibroblast senescence. 
 S1P2 may regulate cellular senescence of 
fibroblasts through multiple mechanisms. The lung 
fibroblasts in S1pr2-/- mice may have been more 
severely exposed to bleomycin compared with WT 
mice. We previously demonstrated that S1P2 in the 
vascular endothelium protects against vascular 
barrier disruption31)32). We observed in S1pr2-/- mice 
that pulmonary vascular leakage at the initial stage 
after starting biweekly injection of bleomycin was 
more severe in S1pr2-/- mice than in WT mice 
(unpublished observation; Zhao J, Okamoto Y and 
Takuwa Y). Therefore, it is likely that fibroblasts in 
S1pr2-/- mice underwent accelerated cellular 
senescence through the enhanced direct toxic effects 
of bleomycin and indirect effects mediated by the 
generation of ROS. Alternatively, cellular senescence 
of S1pr2-/- fibroblasts may be promoted through the 
different regulation of “phosphatase and tensin 
homolog deleted on chromosome 10” (PTEN), which 
is a 3’-specific phosphoinositide phosphatase and 
converts PI-3,4,5-P3 to PI-4,5-P2. Loss of PTEN was 
shown to trigger cellular senescence23). S1P2 was 
previously demonstrated to stimulate PTEN33). 
Consistent with this, WT fibroblasts showed an 
reduction in Akt phosphorylation in response to S1P 
stimulation whereas S1pr2-/- fibroblasts showed 
rather increased Akt phosphorylation in response to 
S1P (Fig. 5A). Therefore, de-inhibition of PTEN in 
S1pr2-/-fibroblasts may also contribute to promotion 
of cellular senescence.
 In summary, the present study demonstrates that 
the loss of S1P2 in lung fibroblasts facilitates 
bleomycin-induced cellular senescence and, thereby, 
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may prohibit progression of lung fibrosis. These 
findings suggest that pharmacological blockade of 
S1P2 may be a novel promising target for treating 
fibrotic disorders.
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